-
Program Rivew | 2023 ASP Brought to A Successful Close
From June 27th to August 19th, 2023, 24 top students from leading global universities participated in the Tsinghua University "Amgen Scholars" program on the Tsinghua campus, completing their 8-week summer research training.Tsinghua University, as a world-renowned institution, possesses international-level academic excellence in the field of biomedical research. In 2018, Tsinghua succes... -
Call for Application for 2023 Tsinghua Amgen Scholars Program
In November 2018, Amgen Foundation expanded the Amgen Scholars Program (ASP) to 24 premier educational and research institutions worldwide. Tsinghua University was selected as the first and currently the only host institution in China and is now accepting global applications. The ASP host institutions for 2019-2023 include 24 leading universities worldwide, such as Harvard University, Stanford ...
-
Professor Zhang Yonghui from the School of Pharmaceutical Sciences and his collaborators published a paper in Cell to propose a strategy for oral drug development targeting integrins
Latest Research ExpressOn September 15, 2022, the Harvard Medical School and the School of Pharmaceutical Sciences of Tsinghua University jointly published a research article entitled “A general chemical principle for creating closure-stabilizing integrin inhibitors” in Cell, introducing the challenges in the research and development of small molecule drugs targeting integrins, and proposing ... -
Ding Sheng and his team from the School of Pharmaceutical Sciences published groundbreaking research findings on totipotent stem cells in Nature
Professor Ding Sheng and his team from the School of Pharmaceutical Sciences have discovered for the first time a drug combination for in vitro directed induction and stable culturing of totipotent stem cells. The breakthrough research findings were published online by Nature on June 21, 2022 (Beijing Time). The research marks the opening of a whole new field of life creation research.1. Revolu...
